{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-242488","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.141002+00:00","generated_at":"2026-05-17T03:24:28.027519+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Bali Muralidhar resigns from Spruce Biosciences board, effective Oct 15","bullets":["Bali Muralidhar, Ph.D. resigned from the Board and compensation committee on October 15, 2025.","Resignation is not due to any disagreement with the Company on operations, policies, or practices.","No replacement named; Board size reduced by one."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-242488","json":"https://secwatch.observer/filing/0001193125-25-242488.json","markdown":"https://secwatch.observer/filing/0001193125-25-242488.md","text":"https://secwatch.observer/filing/0001193125-25-242488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000119312525242488/0001193125-25-242488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000119312525242488/sprb-20251015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:24:28.027519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}